AI MARKET SCANNING

argenx SE

🏛️ NASDAQ 📁 Healthcare 🏭 Biotechnology
AVG HISTORICAL GAP -0.30%
MAX GAP RECORD -4.13%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $ARGX
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Oct 22, 2026 Earnings Release 2026-10-22 (BEFORE OPEN (08:00))
-4.13%
Jul 23, 2026 Earnings Release 2026-07-23 (BEFORE OPEN)
+2.26%
May 07, 2026 Earnings Release 2026-05-07 (AFTER CLOSE)
-0.03%
Feb 26, 2026 Earnings Release 2026-02-26 (BEFORE OPEN)
-1.93%
Oct 30, 2025 Earnings Release 2025-10-30 (AFTER CLOSE)
+1.03%
Aug 05, 2025 Earnings Release 2025-08-05 (BEFORE OPEN)
+0.65%
May 07, 2025 Earnings Release 2025-05-07 (BEFORE OPEN)
+1.28%
Feb 27, 2025 Earnings Release 2025-02-27 (BEFORE OPEN)
+1.22%

VOLATILITY & GAP BIAS

AVG GAP MOVE 1.6%
Bullish Gaps (5)
Bearish Gaps (5)
Neutral / Flat (6)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $ARGX

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

argenx SE, a commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally. The company offers VYVGART for the treatment of gMG and immune thrombocytopenia (ITP), and VYVGART HYTRULO for the treatment of gMG and chronic inflammatory demyelinating…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗